Home
Contact Us
Sitemap
Adare Pharma Solutions on LinkedIn
  • FR
  • DE
  • IT
  • JA
  • ES
Logo: Adare Pharma Solutions

Product Development

  • Capabilities
  • Early Stage Development
  • Research & Development
  • Specialized Services
    • Nitrosamine Mitigation
    • High Potency
    • Small-Scale Non-GMP Laboratory
    • 3D Printing
    • Precision Particle Fabrication™
    • Abuse-Deterrent Testing
  • Analytical Services
  • Formulation Development
  • Pediatric Formulations

Technology Platforms

  • Taste Masking
  • Modified Release
  • Solubility Enhancement
  • Patient-Centric Solutions
  • Orbis Biosciences® Technologies

Specialized Technologies

  • Overview
  • AdvaTab®
  • Diffucaps®
  • Diffutab®
  • Microcaps®
  • Minitabs™
  • Optimμm®
  • Parvulet®
  • Stratμm®
  • Unisun®
  • Adaptdose™
  • Duragran™

Manufacturing & Packaging

  • Technology-Driven CDMO Services
  • Clinical Trial Materials
  • Tech Transfer
  • Commercial-Scale Manufacturing
  • Packaging & Logistical Support

Our Facilities

Quality & Regulatory

About Us

  • Our Legacy
  • Our Leadership
  • Our People
  • Environmental, Social, and Governance

Newsroom

Resource Center

Events

Careers

Contact Us

Product Safety Reporting

Legal Disclaimers

Blog

I need a solution for...

Product Development

  • Capabilities
  • Early Stage Development
  • Research & Development
  • Specialized Services
    • Nitrosamine Mitigation
    • High Potency
    • Small-Scale Non-GMP Laboratory
    • 3D Printing
    • Precision Particle Fabrication™
    • Abuse-Deterrent Testing
  • Analytical Services
  • Formulation Development
  • Pediatric Formulations

Technology Platforms

  • Taste Masking
  • Modified Release
  • Solubility Enhancement
  • Patient-Centric Solutions
  • Orbis Biosciences® Technologies

Specialized Technologies

  • Overview
  • AdvaTab®
  • Diffucaps®
  • Diffutab®
  • Microcaps®
  • Minitabs™
  • Optimμm®
  • Parvulet®
  • Stratμm®
  • Unisun®
  • Adaptdose™
  • Duragran™

Manufacturing & Packaging

  • Technology-Driven CDMO Services
  • Clinical Trial Materials
  • Tech Transfer
  • Commercial-Scale Manufacturing
  • Packaging & Logistical Support

Our Facilities

Quality & Regulatory

About Us

  • Our Legacy
  • Our Leadership
  • Our People
  • Environmental, Social, and Governance

Newsroom

Resource Center

Events

Careers

Contact Us

Product Safety Reporting

Legal Disclaimers

Blog

  • FR
  • DE
  • IT
  • JA
  • ES

Meet With Us

Upcoming Events

 
  • Latest News
    • 01-10-25 Getting Economic Development Done: Governor Shapiro is Making Pennsylvania More Competitive, Attracting Investment, and Creating Jobs

      Over the last two years, the Shapiro Administration has successfully competed for business, made strategic investments in key sectors of the Commonwealth’s... Learn More

    • 10-18-24 The Chamber of Commerce for Greater Philadelphia Announces New Board of Directors and Executive Committee Members, Including Adare CEO Tom Sellig

      FROM THE CHAMBER OF COMMERCE FOR GREATER PHILADELPHIA PHILADELPHIA, PA, October 18, 2024 — The Chamber of Commerce for Greater Philadelphia (the Chamber)... Learn More

    • 09-20-24 Shapiro Administration Invests in PA’s Life Sciences Industry, Celebrates Adare Pharma Solutions’ Relocation of Global Headquarters to Philadelphia from New Jersey

      The Commonwealth’s $2.9 million investment in the growing company will create 115 new, well-paying jobs and retain another 200 existing jobs statewide. FROM... Learn More

    • 09-18-24 Adare And Laxxon Announce 3D-Printing Collaboration

      PHILADELPHIA, PA, September 18, 2024 -- Adare Pharma Solutions, a global technology-driven CDMO focused on oral dosage forms, today announced a collaboration... Learn More

    • View all
  • Events
    • May 14

      New Updates in Drug Formulation & Bioavailability 2025

      Tradeshows

      Meet with us at New Updates in Drug Formulation & Bioavailability 2025 in Basel, CH! Click the...

    • May 14-09

      Webinar: Fierce Pharma Drug Development and Delivery Insights

      Webinars | 13:00:00 | 16:30:00

      Fierce Pharma is excited to launch Drug Development and Delivery Insights for 2025, taking...

    • May 15

      The Future of Swedish & Danish Life Sciences 2025

      Tradeshows

      Meet with us at The Future of Swedish & Danish Life Sciences 2025 in Lund, SE! Click the button...

    • May 20-22

      CPHI Americas 2025

      Tradeshows

      Meet with us at Booth #1312 at CPHI Americas 2025 in Philadelphia, PA! Click the button above or...

    • Jun 02-04

      16th Global DDF Summit – Drug Delivery and Formulation

      Tradeshows

      Meet with us at Stand #14 at the 16th Global DDF Summit - Drug Delivery and Formulation in Berlin,...

    • View all

Our global manufacturing sites meet all cGMP standards, and are optimized for the development and production of specialized oral-dose and injectable delivery systems. And through our in-house regulatory affairs team, Adare can take your product from molecule to market, quickly and efficiently.

— Mike Ryan, Chief Financial Officer & Chief Operations Officer

Adare Pharma Solutions

CORPORATE OFFICES

Headquarters:
7722 Dungan Road
Philadelphia, PA 19111
USA
+1 (215) 288-6500

MANUFACTURING

Via Molise, 16
20098 San Giuliano Milanese (MI)
Italy
+39 02 988981

DEVELOPMENT & MANUFACTURING

Via Martin Luther King, 13
20042 Pessano con Bornago (MI)
Italy
+39 02 954281
845 Center Drive
Vandalia, Ohio 45377
USA
+1 (937) 898-9669
8006 Reeder Street
Lenexa, KS 66214
USA
1100 Orthodox Street
Philadelphia, PA 19124
USA
+1 (215) 288-6500
2500 Molitor Road
Aurora, IL 60502
USA
+1 (630) 888-3820

PACKAGING, WAREHOUSING, & DISTRIBUTION

7722 Dungan Road
Philadelphia, PA 19111
USA
+1 (215) 288-6500

©2025 Adare Pharma Solutions. All rights reserved

  • Privacy Policy
  • Legal Disclaimers
  • Contact Us
Machine Readable Files (cigna.com) Machine Readable Files (anthem.com)